- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
AccuImage wins 510(k) clearance for upgrade
AccuImage wins 510(k) clearance for upgradeAccuImage has received approval from the Food and Drug Administration for its next-generation 3-D software package. The new release can perform high-speed, two- and three-dimensional image processing,
AccuImage wins 510(k) clearance for upgrade
AccuImage has received approval from the Food and Drug Administration for its next-generation 3-D software package. The new release can perform high-speed, two- and three-dimensional image processing, visualization, and transmission between a hospital network and outside networks via the Internet. It runs on Windows 95/98/NT operating systems.
One of the softwares modules, AccuVRT, renders 3-D displays of body structures, and in addition to presurgical planning and postsurgical follow-up, can be used to visualize vascular anomalies, renal disease, and tumor characteristics. Another module, AccuProjector, allows users to perform maximum intensity projection and multiplanar reformatting of medical data, according to the South San Francisco, CA-based firm.
AccuImages software suite can use data from any medical acquisition device vendor. The company has an OEM alliance with Imatron, also of South San Francisco, to provide visualization software for Imatrons ultra-fast CT scanner (PNN 12/98).
- Search again
- Homepage
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
